CompanyGraph
At a glance
- Depends onUpstream position: supplies 8 industries, depends on 0
- PositionP/E ratio is 308×, higher than 95% of its Conglomerates peers (median 25.54×)
- FinancialsAltman Z-Score 2.69: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.89BCNY429.25M · vs all stocks (USD)
Trailing P/E
308.00xvs Conglomerates peers
Revenue (TTM)
721.81MCNY107.20M · vs all stocks (USD)
Profit Margin
1.38%vs Conglomerates peers
Beta
0.4090xvs all stocks
52-Week Change
-23.19%vs all stocks
Market Capitalization
2.89BCNY429.25M · vs all stocks (USD)
Enterprise Value
4.13BCNY613.98M · vs all stocks (USD)
Trailing P/E
308.00xvs Conglomerates peers
Price to Sales (TTM)
4.00xvs Conglomerates peers
Price to Book (MRQ)
6.82xvs Conglomerates peers
Enterprise to Revenue
5.73xvs Conglomerates peers
Enterprise to EBITDA
35.10xvs Conglomerates peers
Gross Margin
27.49%vs Conglomerates peers
Profit Margin
1.38%vs Conglomerates peers
Operating Margin
12.97%vs Conglomerates peers
Return on Assets (TTM)
2.92%vs Conglomerates peers
Return on Equity (TTM)
6.00%vs Conglomerates peers
Revenue (TTM)
721.81MCNY107.20M · vs all stocks (USD)
Revenue per Share (TTM)
2.24CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-12.00%vs Conglomerates peers
Gross Profit (TTM)
210.20MCNY31.22M · vs all stocks (USD)
EBITDA (TTM)
133.81MCNY19.87M · vs all stocks (USD)
Net Income (TTM)
9.94MCNY1.48M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
31.30%vs Conglomerates peers
Operating Cash Flow (TTM)
129.47MCNY19.23M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
25.12MCNY3.73M · vs all stocks (USD)
5-Year Average Dividend Yield
0.28%vs all stocks
Payout Ratio
0.00%vs Conglomerates peers
Minority Interest (Equity)
199.63MCNYFY2025 · Dec 31, 2025Revenue
744.74MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
534.41MCNYFY2025 · Dec 31, 2025Gross Profit
210.33MCNYFY2025 · Dec 31, 2025Operating Income
86.28MCNY12.81M · vs all stocks (USD)
Pre-tax Income
72.58MCNYFY2025 · Dec 31, 2025Income Tax Expense
24.31MCNYFY2025 · Dec 31, 2025Net Income
48.28MCNYFY2025 · Dec 31, 2025EBIT
91.02MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
133.81MCNYFY2025 · Dec 31, 2025Research & Development
7.47MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
43.99MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.10MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
18.44MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
294.75MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
294.75MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
48.28MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-39.43MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
76.66MCNYFY2025 · Dec 31, 2025Free Cash Flow
55.20MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
454.57MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
48.28MCNYFY2025 · Dec 31, 2025Other Non-cash Items
29.78MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
5.27MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.67MCNYFY2025 · Dec 31, 2025Capital Expenditures
-21.46MCNYFY2025 · Dec 31, 2025Purchase of Investments
-392.90MCNYFY2025 · Dec 31, 2025Sale of Investments
423.39MCNYFY2025 · Dec 31, 2025Other Investing Activity
-444.90KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
8.59MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
518.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-496.55MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-6.28MCNYFY2025 · Dec 31, 2025Other Financing Charges
-43.36MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-28.18MCNYFY2025 · Dec 31, 2025Shares Outstanding
312.79MSharesUpdated Aug 20, 2026Float Shares
242.28MSharesUpdated Aug 20, 2026% Held by Insiders
54.49%vs all stocks
% Held by Institutions
1.48%vs all stocks
Total Cash (MRQ)
478.62MCNY71.09M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.04CNYUpdated Aug 20, 2026Total Debt (MRQ)
528.26MCNY78.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6342xvs Conglomerates peers
Current Ratio (MRQ)
1.65xvs Conglomerates peers
Book Value per Share (MRQ)
1.35CNYUpdated Aug 20, 2026Total Assets
1.79BCNY265.37M · vs all stocks (USD)
Total Current Assets
757.64MCNYFY2025 · Dec 31, 2025Total Liabilities
977.85MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.03BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
487.09MCNYFY2025 · Dec 31, 2025Total Current Liabilities
490.76MCNYFY2025 · Dec 31, 2025Cash
453.11MCNYFY2025 · Dec 31, 2025Cash Equivalents
5.59MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
458.70MCNYFY2025 · Dec 31, 2025Other Short-term Investments
20.01MCNYFY2025 · Dec 31, 2025Accounts Receivable
156.32MCNYFY2025 · Dec 31, 2025Inventory
48.02MCNYFY2025 · Dec 31, 2025Accounts Payable
271.86MCNYFY2025 · Dec 31, 2025Short-term Debt
107.59MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.71MCNYFY2025 · Dec 31, 2025Long-term Debt
404.91MCNYFY2025 · Dec 31, 2025Common Stock (Book)
310.59MCNYFY2025 · Dec 31, 2025Retained Earnings
188.86MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
808.93MCNY120.14M · vs all stocks (USD)
52-Week Low
7.47CNYUpdated Aug 20, 202652-Week High
16.08CNYUpdated Aug 20, 202652-Week Change
-23.19%vs all stocks
Beta
0.4090xvs all stocks
50-Day MA
8.18CNYUpdated Aug 20, 2026200-Day MA
10.50CNYUpdated Aug 20, 2026Avg 10-Day Volume
7.64MSharesUpdated Aug 20, 2026Avg 30-Day Volume
7.64MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.0300CNYUpdated Aug 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 308×, higher than 95% of its Conglomerates peers (median 25.54×)Significant
P/E ratio: 308Industry median: 25.54Industry P95: 133.783Peers compared: 104
Financial Health
Altman Z-Score 2.69: safe zoneNotable
Altman Z-Score: 2.69
High earnings qualityNotable
Earnings Quality Score: 1.31
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Cross Country Healthcare Inc.
Tier 1InterfaceThroughput-Bound ConversionFlowSenseMaking
Discount Investment Corporation Ltd.
Tier 1InterfaceThroughput-Bound ConversionRiskFlow
Yangzhou Jinquan Tourism Co., Ltd.
Tier 1InterfaceThroughput-Bound ConversionAttentionFlow
Transcom Inc.
Tier 1InterfaceThroughput-Bound ConversionFlowAttention
BGF Co., Ltd.
Tier 1InterfaceThroughput-Bound ConversionFlowAttention
Beijing Electronic Zone Co., Ltd.
Tier 1InterfaceThroughput-Bound ConversionFlowSenseMaking
Xiamen Anne Corp
Tier 1InterfaceThroughput-Bound ConversionSenseMakingFlow
Tential Inc.
Tier 1InterfaceThroughput-Bound ConversionFlowSenseMaking
Amn Healthcare Services Inc.
Tier 1InterfaceThroughput-Bound ConversionFlowSenseMaking
Shanghai Foreign Service Co., Ltd.
Tier 1InterfaceThroughput-Bound ConversionSenseMakingFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Aptiv PLC
2 interpretationsDrawdown With FCF And Cash BackingClose Below 40W SMA With Profitability
Bright Horizons Family Solutions Inc.
2 interpretationsDrawdown With FCF And Cash BackingClose Below 40W SMA With Profitability
Collegium Pharmaceutical Inc.
2 interpretationsDrawdown With FCF And Cash BackingClose Below 40W SMA With Profitability